The subsidiary of Tianshi (600535.SH) obtained a drug registration certificate for injectable indoline green

Zhitongcaijing · 1d ago

Zhitong Finance App News, Tasly (600535.SH) issued an announcement. Recently, Tianjin Tianshili Zhijiao Pharmaceutical Co., Ltd., a wholly-owned subsidiary of the company, received the “Drug Registration Certificate” for injectable indoline green approved and issued by the State Drug Administration. Injectable indocyanine green is clinically used to diagnose various liver diseases such as cirrhosis, hepatic fibrosis, tenacious hepatitis, and occupational and drug-toxic liver disease to understand the extent of liver damage and reserve function; it can also be used for choroidal angiography to determine the location of choroidal diseases. The drug is registered as a chemical in category 3, and is treated as if it has passed the generic drug consistency evaluation.